0

    524602

    BANDARAM

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    BANDARAM PHARMA PACKTECH LIMIT Share Price Today

    Investment Returns

    Over 1 Month -23.78% Over 3 Months -15.94% Over 6 Months -30.80% Over 1 Year -46.79%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    BANDARAM PHARMA PACKTECH LIMIT fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 39.00
    • P/E Ratio (TTM) -33.94
    • Beta 0.30
    • Book Value / share 12.73
    • Return on equity 1.15%
    • EPS (TTM) 0.00
    • Dividend yield [-]%
    • Net profit/quarter (Cr) -0.33
    info icon alternate text

    BANDARAM PHARMA PACKTECH LIMIT Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 8.20
    Operating Expense 8.53
    Net Profit -0.33
    Net Profit Margin (%) -4.02
    Earnings Per Share (EPS) -0.18
    EBITDA -0.33
    Effective Tax Rate (%) 0.00
    Particulars DEC 2025 (Values in Cr)
    Revenue 1.68
    Operating Expense 1.89
    Net Profit -0.21
    Net Profit Margin (%) -12.50
    Earnings Per Share (EPS) -0.12
    EBITDA -0.21
    Effective Tax Rate (%) 0.00
    Particulars SEP 2025 (Values in Cr)
    Revenue 0.33
    Operating Expense 0.68
    Net Profit -0.35
    Net Profit Margin (%) -106.06
    Earnings Per Share (EPS) -0.29
    EBITDA -0.35
    Effective Tax Rate (%) 0.00
    Particulars JUN 2025 (Values in Cr)
    Revenue 0.76
    Operating Expense 1.03
    Net Profit -0.27
    Net Profit Margin (%) -35.52
    Earnings Per Share (EPS) -0.22
    EBITDA -0.27
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 3.71
    Operating Expense 3.75
    Net Profit 0.04
    Net Profit Margin (%) 1.07
    Earnings Per Share (EPS) 0.04
    EBITDA 0.06
    Effective Tax Rate (%) 16.66
    Particulars MAR 2026 (Values in Cr)
    Revenue 10.96
    Operating Expense 12.13
    Net Profit -1.16
    Net Profit Margin (%) -10.58
    Earnings Per Share (EPS) -0.64
    EBITDA -1.16
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 12.23
    Operating Expense 12.14
    Net Profit 0.14
    Net Profit Margin (%) 1.14
    Earnings Per Share (EPS) 0.12
    EBITDA 0.20
    Effective Tax Rate (%) 26.31
    Particulars MAR 2024 (Values in Cr)
    Revenue 14.84
    Operating Expense 14.69
    Net Profit 0.13
    Net Profit Margin (%) 0.87
    Earnings Per Share (EPS) 0.11
    EBITDA 0.19
    Effective Tax Rate (%) 23.52
    Particulars MAR 2023 (Values in Cr)
    Revenue 10.09
    Operating Expense 9.82
    Net Profit 0.20
    Net Profit Margin (%) 1.98
    Earnings Per Share (EPS) 0.68
    EBITDA 0.27
    Effective Tax Rate (%) 25.92
    Particulars MAR 2022 (Values in Cr)
    Revenue 0.00
    Operating Expense 0.01
    Net Profit -0.01
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -0.03
    EBITDA -0.01
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 10.54
    ROE % 7.94
    ROCE % 8.47
    Total Debt to Total Equity 1.18
    EBITDA Margin 7.90
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 10.23
    ROE % 12.37
    ROCE % 10.15
    Total Debt to Total Equity 1.72
    EBITDA Margin 8.36
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 10.28
    ROE % 8.44
    ROCE % 4.40
    Total Debt to Total Equity 4.61
    EBITDA Margin 7.15
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 10.09
    ROE % 1.15
    ROCE % 1.37
    Total Debt to Total Equity 0.14
    EBITDA Margin 1.55
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 10.17
    ROE % 1.70
    ROCE % 1.73
    Total Debt to Total Equity 0.29
    EBITDA Margin 1.28
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 10.25
    ROE % 6.60
    ROCE % 5.16
    Total Debt to Total Equity 0.73
    EBITDA Margin 2.68
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 9.97
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 2.17
    EBITDA Margin 0.00
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share -10.18
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin 0.00
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.11
    Total Assets 38.91
    Total Liabilities 38.91
    Total Equity 15.82
    Share Outstanding 1
    Price to Book Ratio 4.60
    Return on Assets (%) 2.55
    Return on Capital (%) 3.01
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.04
    Total Assets 32.05
    Total Liabilities 32.05
    Total Equity 15.06
    Share Outstanding 1
    Price to Book Ratio 3.64
    Return on Assets (%) 2.95
    Return on Capital (%) 3.48
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.15
    Total Assets 20.17
    Total Liabilities 20.17
    Total Equity 5.13
    Share Outstanding 0
    Price to Book Ratio 7.12
    Return on Assets (%) 0.70
    Return on Capital (%) 0.73
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.01
    Total Assets 19.20
    Total Liabilities 19.20
    Total Equity 12.10
    Share Outstanding 1
    Price to Book Ratio 4.60
    Return on Assets (%) 0.72
    Return on Capital (%) 0.9
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.04
    Total Assets 13.35
    Total Liabilities 13.35
    Total Equity 12.20
    Share Outstanding 1
    Price to Book Ratio 3.64
    Return on Assets (%) 0.96
    Return on Capital (%) 1.05
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.08
    Total Assets 8.26
    Total Liabilities 8.26
    Total Equity 3.07
    Share Outstanding 0
    Price to Book Ratio 7.12
    Return on Assets (%) 2.46
    Return on Capital (%) 2.73
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 2.08
    Total Assets 2.99
    Total Liabilities 2.99
    Total Equity 2.98
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) -0.33
    Return on Capital (%) -0.34
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.00
    Total Assets 1.26
    Total Liabilities 1.26
    Total Equity -2.31
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) -2.50
    Return on Capital (%) 3.65
    Particulars MAR 2025 (Values in Cr)
    Net Income 1.31
    Cash from Operations -4.60
    Cash from Investing -0.07
    Cash from Financing 5.08
    Net change in Cash 0.07
    Free Cash Flow -4.52
    Particulars MAR 2024 (Values in Cr)
    Net Income 1.18
    Cash from Operations -3.91
    Cash from Investing -1.57
    Cash from Financing 5.59
    Net change in Cash -0.11
    Free Cash Flow -3.73
    Particulars MAR 2023 (Values in Cr)
    Net Income 0.32
    Cash from Operations -1.09
    Cash from Investing -5.30
    Cash from Financing 4.46
    Net change in Cash -1.93
    Free Cash Flow 1.69
    Particulars MAR 2025 (Values in Cr)
    Net Income 0.18
    Cash from Operations -3.20
    Cash from Investing 0.00
    Cash from Financing 3.22
    Net change in Cash -0.02
    Free Cash Flow -3.20
    Particulars MAR 2024 (Values in Cr)
    Net Income 0.17
    Cash from Operations -3.21
    Cash from Investing -1.40
    Cash from Financing 4.61
    Net change in Cash -0.04
    Free Cash Flow -3.21
    Particulars MAR 2023 (Values in Cr)
    Net Income 0.27
    Cash from Operations -3.86
    Cash from Investing -2.53
    Cash from Financing 4.40
    Net change in Cash -1.99
    Free Cash Flow -3.84
    Particulars MAR 2022 (Values in Cr)
    Net Income -0.01
    Cash from Operations 2.91
    Cash from Investing -1.55
    Cash from Financing 0.72
    Net change in Cash 2.08
    Free Cash Flow 2.91
    Particulars MAR 2021 (Values in Cr)
    Net Income -0.03
    Cash from Operations 0.00
    Cash from Investing 0.00
    Cash from Financing 0.00
    Net change in Cash 0.00
    Free Cash Flow 0.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTERPRISE LT 8897.35 65.40 13.50 127930.24 6680.00 8917.95
    FORTIS MALAR HOSPITALS LIMITED 52.38 23.70 2.85 98.17 40.75 76.00
    SHREE PACETRONIX LTD. 129.50 15.45 2.72 48.56 71.00 283.15
    TRANSGENE BIOTEK LTD. 2.96 0.00 2.67 22.43 1.83 5.26
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTERPRISE LT 8897.35 85.22 12.84 127930.24 6680.00 8917.95
    [-] 0.0 0.0 0.0 0.0 0.0 0.0
    CHENNAI MEENAKSHI MULTISPECIAL 38.43 0.00 -9.35 28.71 30.30 57.48
    KOVAI MEDICAL CENTER & HO 6041.50 27.04 5.00 6609.40 5010.00 6725.00

    BANDARAM PHARMA PACKTECH LIMIT shareholding pattern

    Holding
    37.33%
    62.66%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    BANDARAM PHARMA PACKTECH LIMIT Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    21.72 -6.78 redarrow
    red-green-graph indicator
    16 Bearish
    0 Bullish
    • 5 Days 24.90
    • 26 Days 27.70
    • 10 Days 26.50
    • 50 Days 27.90
    • 12 Days 26.80
    • 100 Days 28.30
    • 20 Days 27.50
    • 200 Days 30.00
    24.10 PIVOT
    First Support 22.20 First Resistance 25.19 Second Support 21.11 Second Resistance 27.09 Third Support 19.21 Third Resistance 28.18
    RSI 27.96 ADX 23.39 MACD -0.85 Williams % R -94.32 Commodity Channel Index (CCI) -292.52
    Date 2026-07-03 Week 17436.00 Same Day 17602.00 Month 5321.00
    1 Year 0.30 3 Year 0.19
    Over 1 Month
    -23.78% down
    Over 1 Year
    -46.79% down
    Over 3 Months
    -15.94% down
    Over 3 Years
    -8.09% down
    Over 6 Months
    -30.80% down
    Over 5 Years
    0.00% down

    BANDARAM PHARMA PACKTECH LIMIT Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    22 Sep 2025 0.1 Final 22 Sep 2025 Equity shares
    20 Sep 2024 0.1 Final 21 Sep 2024 Equity shares
    22 Sep 2023 0.1 Final 23 Sep 2023 Equity shares

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Bandaram Pharma Packtech Ltd?

    Answer Field

    Bandaram Pharma Packtech Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 21.72 as on Jul 03 2026 03:30 PM.

    What is the Market Cap of Bandaram Pharma Packtech Ltd Share?

    Answer Field

    The market cap of Bandaram Pharma Packtech Ltd for NSE ₹ 0.00 & for BSE ₹ 39.00 as on Jul 03 2026 03:30 PM.

    What is the 52 Week High and Low of Bandaram Pharma Packtech Ltd?

    Answer Field

    The 52 Week High and Low of Bandaram Pharma Packtech Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 49.70 and ₹ 20.95.

    What is 1 year return for Bandaram Pharma Packtech Ltd?

    Answer Field

    The 1 year returns on the stock has been -46.79%.

    What is the P/E Ratio of Bandaram Pharma Packtech Ltd Share?

    Answer Field

    As on Jul 03 2026 03:30 PM the price-to-earnings (PE) ratio for Bandaram Pharma Packtech Ltd share is -33.94.

    What is the PB ratio of Bandaram Pharma Packtech Ltd Share?

    Answer Field

    As on Jul 03 2026 03:30 PM, the price-to-book (PB) ratio for Bandaram Pharma Packtech Ltd share is 12.73.

    How to Buy Bandaram Pharma Packtech Ltd Share?

    Answer Field

    You can trade in Bandaram Pharma Packtech Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Bandaram Pharma Packtech Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Bandaram Pharma Packtech Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Bandaram Pharma Packtech Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |